PE Ratio: 78.66

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/E ratio high or low?

The P/E ratio of 78.66 is 33% above its 4-year average of 59.24, near the low end of its 4-year range (4.03–1015.00).

As of 2026-10-06T20:52:05.135Z. 3.10% above its 12-month average of 76.29.

PE Ratio (78.66) = Close Price ($77.09) / Diluted TTM EPS ($0.98)

KNSA PE Ratio Metrics

P/E vs. its own history

At 78.7, P/E is near its 4-year median — higher than 58% of readings in its 4-year history.

P/E Comparison

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PE Ratio FAQ

What is the P/E ratio for Kiniksa Pharmaceuticals International, plc (KNSA)?

The P/E ratio for KNSA stock is 78.66.

Is Kiniksa Pharmaceuticals International, plc's P/E ratio high or low?

The P/E ratio of 78.66 is 33% above its 4-year average of 59.24, near the low end of its 4-year range (4.03–1015.00).

What is the TTM average P/E ratio for Kiniksa Pharmaceuticals International, plc (KNSA)?

The TTM average P/E ratio for KNSA stock is 76.29.

What is the 3Y average P/E ratio for Kiniksa Pharmaceuticals International, plc (KNSA)?

The 3Y average P/E ratio for KNSA stock is 93.46.

Showing the most recent 260 of 650 data points. The chart above shows the full history.

Related Metrics